MedPath

Evaluation of the therapeutic effect of rTMS on negative symptoms in schizophrenic patients

Not Applicable
Conditions
Schizophrenia.
Schizophrenia
Registration Number
IRCT20211029052909N1
Lead Sponsor
Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
66
Inclusion Criteria

Patients with schizophrenia with negative symptoms
Be treated with antipsychotics
The patient is in the maintenance phase

Exclusion Criteria

Depression
Seizure
Pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
egative symptoms in schizophrenic patients like poverty of speech, apathy, social withdrawal. Timepoint: One day before starting treatment? One day after the end of treatment, Three weeks after the end of treatment. Method of measurement: The Positive and Negative Syndrome Scale (PANSS).
Secondary Outcome Measures
NameTimeMethod
Score obtained from Positive and Negative Syndrome Scale. Timepoint: One day before starting treatment?, One day after the end of treatment, Three weeks after the end of treatment. Method of measurement: PANSS.
© Copyright 2025. All Rights Reserved by MedPath